Physician

Aaron Miller, M.D.

According to 2025 Medicare claims, Aaron Miller, M.D. (NPI: 1598736811) practices neurology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (NPI: 1558627844; TIN: 611661781) and primary practice location at 10029-6501. Miller is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Miller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 147 traditional Medicare patients, billed 467 HCPCS/CPT codes, and received $33,030 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 64 prescription claims across 26 beneficiaries totaling $15,885 in drug costs, led by Mycophenolate Mofetil (Mycophenolate Mofetil). 2023 DME data shows 11 claims. Open Payments data shows 12 records totaling $13,046. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $24,576 to $33,030. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $2,371,634 to $15,885. For DME billing, reported payments moved sharply higher in recent years, from $4,422 to $44,025.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	147	287	$24,576
2016	132	290	$25,573
2017	133	336	$29,773
2018	154	319	$28,671
2019	143	285	$26,463
2020	116	197	$18,106
2021	140	253	$32,089
2022	145	263	$30,930
2023	141	252	$30,953
2024	147	467	$33,030

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	97	632	$2,371,634
2016	80	549	$2,266,351
2017	72	489	$2,352,003
2018	70	549	$1,864,899
2019	57	283	$937,726
2020	41	154	$372,804
2021	42	146	$411,865
2022	36	97	$191,950
2023	32	101	$36,448
2024	26	64	$15,885

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	23	$752
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	23	$944
2023	N/R	11	$521
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	11	11	$196
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	62	105	$145
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	79	120	$101
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	134	222	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mycophenolate Mofetil	Mycophenolate Mofetil	15	690	$2,195

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$13,046	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Miller, M.D.?

Tedicare shows public-source Medicare data for Aaron Miller, M.D. (NPI 1598736811), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Miller, M.D. have ACO affiliation data?

Aaron Miller, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Aaron Miller, M.D.?

Aaron Miller, M.D. is linked to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (billing NPI 1558627844) in the available physician profile data.

Does Aaron Miller, M.D. have Open Payments data?

Aaron Miller, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.